XML 24 R12.htm IDEA: XBRL DOCUMENT
v3.19.1

Stock-Based Compensation | 12 Months Ended
--- | ---
Dec. 31, 2018
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] |
Stock-Based Compensation | Note 5: Stock-Based Compensation Equity Compensation Plans Common Stock Option Plans In 2000, the Company adopted the 2000 Stock Plan, which was amended in 2004 (“Amended 2000 Plan”), and terminated in 2010. As of December 31, 2018, no options were available for future issuance under the Amended 2000 Plan, as the remaining options outstanding under the Amended 2000 Plan expired in June 2016. In June 2010, the Company’s stockholders approved the 2010 Equity Incentive Plan, which was amended and restated in 2014 and amended again in 2017 and 2018 (“Amended 2010 Plan”). The Amended 2010 Plan authorizes the board of directors or the compensation committee of the board of directors to grant a broad range of awards, including stock options, stock appreciation rights, restricted stock, performance-based awards, and restricted stock units. Under the Amended 2010 Plan, 400,000 shares were initially reserved for issuance. In June 2014, December 2017 and December 2018, the Company’s stockholders approved to the Amended 2010 Plan to increase the number of shares reserved for issuance by 150,000, 200,000 and 4,000,000 shares, respectively. In addition, the terms of the Amended 2010 Plan provide for an automatic annual increase in the share reserve of 50,000 on January 1 of each year. The Amended 2010 Plan has a 10-year term and provides for annual option grants or other awards to non-employee directors to acquire up to 40,000 shares and for a one-time grant of an option or other award to a non-employee director to acquire up to 120,000 shares upon initial appointment or election to the board of directors. The term of options granted under the Amended 2010 Plan may not exceed ten years. The term of all incentive stock options granted to a person who, at the time of grant, owns stock representing more than 10% of the voting power of all classes of the Company’s stock may not exceed five years. The exercise price of stock options granted under the Amended 2010 Plan must be at least equal to the fair market value of the shares on the date of grant. Generally, options granted under the Amended 2010 Plan will vest over a four-year period and will have a six or ten-year term. In addition, the Amended 2010 Plan provides for automatic acceleration of vesting for options granted to non-employee directors upon a change of control of the Company. The Amended 2000 Plan and Amended 2010 Plan are referred to collectively as the “Plans.” The Company may also award shares to new employees outside the Plans, as material inducements to the acceptance of employment with the Company, as permitted under the Listing Rules of the Nasdaq Stock Market. These awards must be approved by the compensation committee of the board of directors, a majority of the independent directors or, below a specified share level, by an authorized executive officer. As of December 31, 2018 and 2017, no such awards were outstanding. Employee Stock Purchase Plan In June 2010, the Company’s stockholders approved the 2010 Employee Stock Purchase Plan (“ESPP”). A total of 200,000 shares of common stock were initially reserved for issuance under the ESPP in 2010. On September 1, 2010, the Company commenced the first offering period under the ESPP. In May 2015, the Company’s stockholders approved an amendment increasing the number of shares reserved for issuance by 200,000 shares. The ESPP, which is intended to qualify under Section 423 of the IRC, is administered by the board of directors or the compensation committee of the board of directors. The ESPP provides that eligible employees may purchase up to $25,000 worth of the Company’s common stock annually over the course of two six-month offering periods. The purchase price to be paid by participants is 85% of the price per share of the Company’s common stock either at the beginning or the end of each six-month offering period, whichever is less. On February 29, 2016, approximately 37,300 shares of common stock were issued at an aggregate purchase price of $197,000 under the ESPP. On August 31, 2016, approximately 31,900 shares of common stock were issued at an aggregate purchase price of $167,000 under the ESPP. In February 2017, the Company’s board of directors canceled the ESPP purchase period that began September 1, 2016 and directed the Company to refund outstanding payroll contributions. As of December 31, 2018, there were approximately 150,000 shares authorized and unissued under the ESPP. Stock-Based Compensation Expense The unamortized compensation cost, net of expected forfeitures, as of December 31, 2018 was $0.3 million related to stock options and is expected to be recognized as expense over a weighted average period of approximately 0.8 years. The unamortized compensation cost, net of expected forfeitures, as of December 31, 2018 was $0.1 million related to restricted stock units and is expected to be recognized as expense over a weighted average period of approximately 0.3 years. For the year ended December 31, 2018, the fair value of options and awards vested was approximately $0.7 million. The Company is required to present the tax benefits resulting from tax deductions in excess of the compensation cost recognized from the exercise of stock options as financing cash flows in the consolidated statements of cash flows. For the years ended December 31, 2018, 2017 and 2016, there were no such tax benefits associated with the exercise of stock options. Valuation Assumptions and Expense Information for Stock-based Compensation The fair value of the Company’s share-based payment awards for the years ended December 31, 2018, 2017 and 2016 was estimated on the grant dates using the Black-Scholes valuation option-pricing model with the following assumptions:
|  | Year Ended
|  | December 31,
|  | 2018 |  |  | 2017 |  |  | 2016
Risk-free interest rate |  | 2.2% |  |  | 1.6% - 1.8% |  |  | 1% - 2.1%
Volatility |  | 109.5% |  |  | 70.2% - 101.5% |  |  | 61.4% - 65.0%
Expected life (years) |  |  | 4.0 |  |  |  | 4.0 |  |  | 3.0 - 5.0
Dividend yield |  | 0 % |  |  | 0 % |  |  | 0 %
The risk-free interest rate was derived from the Daily Treasury Yield Curve Rates as published by the U.S. Department of the Treasury as of the grant date for terms equal to the expected terms of the options. The expected volatility was based on the historical volatility of the Company’s stock price over the expected term of the options. The expected term of options granted was derived from historical data based on employee exercises and post-vesting employment termination behavior. A dividend yield of zero is applied because the Company has never paid dividends and has no intention to pay dividends in the near future. The stock-based compensation expense recorded is adjusted based on estimated forfeiture rates. An annualized forfeiture rate has been used as a best estimate of future forfeitures based on the Company’s historical forfeiture experience. The stock-based compensation expense will be adjusted in later periods if the actual forfeiture rate is different from the estimate. Common Stock Options and Restricted Stock A summary of stock option and restricted stock unit (“RSU”) award activity under the Plans is presented below (in thousands, except exercise price):
|  |  |  |  |  | Options outstanding |
|  |  |  |  |  |  |  |  |  | Weighted |
|  | Shares |  |  |  |  |  |  | Average |
|  | Available |  |  | Number of |  |  | Exercise |
|  | for Grant |  |  | Shares |  |  | Prices |
Balance at January 1, 2016 |  |  | 106 |  |  |  | 675 |  |  | $ | 35.10 |
Additional shares authorized under the Plan |  |  | 50 |  |  |  | — |  |  |  | — |
RSUs granted |  |  | (144 | ) |  |  | — |  |  |  | — |
RSUs cancelled and returned to the Plan |  |  | 7 |  |  |  | — |  |  |  | — |
Options granted |  |  | (384 | ) |  |  | 384 |  |  | $ | 6.96 |
Options cancelled and returned to the Plan |  |  | 479 |  |  |  | (479 | ) |  | $ | 35.64 |
Options cancelled and expired |  |  | — |  |  |  | (58 | ) |  | $ | 44.80 |
Balance at December 31, 2016 |  |  | 114 |  |  |  | 522 |  |  | $ | 13.88 |
Additional shares authorized under the Plan |  |  | 250 |  |  |  | — |  |  |  | — |
RSUs granted |  |  | (407 | ) |  |  | — |  |  |  | — |
RSUs cancelled and returned to the Plan |  |  | 59 |  |  |  | — |  |  |  | — |
Options granted |  |  | (160 | ) |  |  | 160 |  |  | $ | 0.76 |
Options cancelled and returned to the Plan |  |  | 375 |  |  |  | (375 | ) |  | $ | 15.69 |
Balance at December 31, 2017 |  |  | 231 |  |  |  | 307 |  |  | $ | 4.81 |
Additional shares authorized under the Plan |  |  | 4,050 |  |  |  | — |  |  |  | — |
RSUs granted |  |  | (268 | ) |  |  | — |  |  |  | — |
RSUs cancelled and returned to the Plan |  |  | 24 |  |  |  | — |  |  |  | — |
Options granted |  |  | (40 | ) |  |  | 40 |  |  | $ | 1.28 |
Options cancelled and returned to the Plan |  |  | 10 |  |  |  | (10 | ) |  | $ | 11.63 |
Balance at December 31, 2018 |  |  | 4,007 |  |  |  | 337 |  |  | $ | 4.19 |
In 2016, the Company initiated a one-time option exchange program pursuant to which employees (excluding the chief executive officer and non-employees, including members of the Company’s board of directors) who held certain options to purchase shares of the Company’s common stock (such options, eligible options) were given the opportunity to exchange such eligible options for a lesser number of replacement options with a lower exercise price. Upon the expiration of the option exchange program on August 23, 2016, the Company accepted for cancellation exchanged options to purchase an aggregate of 456,995 shares of common stock and issued replacement options covering 334,027 shares of common stock from the Amended 2010 Plan. The exchanged eligible options included options to purchase 113,531 shares of the Company’s common stock, which were originally inducement grants. The replacement options have an exercise price of $7.20 per share and vest monthly over three years. This one-time option exchange was treated as a modification for accounting purposes and resulted in incremental expense of approximately $926,000, which was calculated using the Black-Scholes option pricing model. The incremental expense and the unamortized expense remaining on the exchanged options are being amortized over the three-year vesting period of the replacement options. A summary of RSU activity under the Plans is presented below (in thousands, except fair value):
|  |  |  |  |  | Weighted |
|  |  |  |  |  | Average |
|  | Number of |  |  | Grant-Date |
|  | Shares |  |  | Fair Value |
Non-vested shares at January 1, 2016 |  |  | 24 |  |  | $ | 47.17 |
Granted |  |  | 144 |  |  | $ | 5.30 |
Vested |  |  | (12 | ) |  | $ | 46.06 |
Cancelled |  |  | (8 | ) |  | $ | 15.67 |
Non-vested shares at December 31, 2016 |  |  | 148 |  |  | $ | 8.13 |
Granted |  |  | 407 |  |  | $ | 0.93 |
Vested |  |  | (120 | ) |  | $ | 5.76 |
Cancelled |  |  | (59 | ) |  | $ | 5.04 |
Non-vested shares at December 31, 2017 |  |  | 376 |  |  | $ | 1.58 |
Granted |  |  | 268 |  |  | $ | 0.89 |
Vested |  |  | (348 | ) |  | $ | 1.34 |
Cancelled |  |  | (24 | ) |  | $ | 1.21 |
Non-vested shares at December 31, 2018 |  |  | 272 |  |  | $ | 1.22 |
The total intrinsic value of the RSUs outstanding as of December 31, 2018 was $0.1 million. The following table summarizes significant ranges of outstanding and exercisable options as of December 31, 2018 (in thousands, except contractual life and exercise price):
|  | Options Outstanding |  |  | Options Exercisable |
|  |  |  |  |  | Weighted |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  |  |  |  |  | Average |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  |  |  |  |  | Remaining |  |  | Weighted |  |  |  |  |  |  | Weighted |  |  |  |  |
|  |  |  |  |  | Contractual |  |  | Average |  |  |  |  |  |  | Average |  |  | Aggregate |
|  | Number |  |  | Life |  |  | Exercise |  |  | Number |  |  | Exercise |  |  | Intrinsic |
Range of Exercise Price |  | Outstanding |  |  | (in Years) |  |  | Price |  |  | Exercisable |  |  | Price |  |  | value |
$0.75 - $1.27 |  |  | 159 |  |  |  | 4.80 |  |  | $ | 0.75 |  |  |  | 53 |  |  | $ | 0.75 |  |  | $ | — |
$1.28 - $7.19 |  |  | 51 |  |  |  | 5.40 |  |  | $ | 2.09 |  |  |  | 22 |  |  | $ | 2.85 |  |  | $ | — |
$7.20 - $20.49 |  |  | 108 |  |  |  | 7.29 |  |  | $ | 7.20 |  |  |  | 84 |  |  | $ | 7.20 |  |  | $ | — |
$20.50 - $46.20 |  |  | 19 |  |  |  | 6.19 |  |  | $ | 21.53 |  |  |  | 19 |  |  | $ | 21.55 |  |  | $ | — |
$0.75 - $46.20 |  |  | 337 |  |  |  | 5.77 |  |  | $ | 4.19 |  |  |  | 178 |  |  | $ | 6.25 |  |  | $ | — |
Vested and expected to vest |  |  | 303 |  |  |  | 5.85 |  |  | $ | 4.52 |  |  |  |  |  |  |  |  |  |  | $ | — |
Exercisable |  |  | 178 |  |  |  | 6.11 |  |  | $ | 6.25 |  |  |  |  |  |  |  |  |  |  | $ | — |
There were no stock options exercised during the years ended December 31, 2018, 2017, or 2016. The intrinsic value of outstanding options as of December 31, 2018 was zero.

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -URI http://asc.fasb.org/subtopic&trid=2208855 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration